HIV-1 resistance testing from proviral DNA

Size: px
Start display at page:

Download "HIV-1 resistance testing from proviral DNA"

Transcription

1 HIV-1 resistance testing from proviral DNA Alexander Thielen AREVIR 2018

2 Resistance testing from proviral DNA? amount of samples with low viral loads increasing desire to switch under successful therapy

3 Zusammensetzung der Viruslasten (jeweils Q2, Kaiserslautern) 100% 90% 80% amount of samples with low viral loads increasing 70% 60% 50% 40% 30% desire to switch under successful therapy studies, e.g. the LOWER study >1000 Kop/ml Kop/ml Kop/ml Kop/ml <50 Kop/ml 20% 10% 0% Däumer, M., 2018, unpublished

4 Resistenzteste 2017, KL Plasma RNA: 913 Provirale DNA: Plasma-RNA provirale DNA 2017 provirale DNA 2010 Däumer, M., 2018, unpublished

5 Resistance testing from proviral DNA? amount of samples with low viral loads increasing desire to switch under successful therapy studies, e.g. the LOWER study

6 The LOWER study Limited Options with Extended Resistance to antiretroviral therapy: A National Survey of Triple Class Resistance (LOWER) headed by PD Dr. med. Christian Hoffmann analysis of HIV patients with triple class resistance resistance testing from proviral DNA with NGS comparison of current resistance status with historical data

7 Resistance testing from proviral DNA

8 Resistance testing from proviral DNA problem: not only old populations archived but also hypermutated reads Apobec 3F/3G mutations (G to A) in DNA: Apobec3F: GA AA Apobec3G: GG AG, further preference for TGG, TGGG motifs! so, what is really there?

9 How to detect Apobec mutations typical mutations: ATG ATA M I GGY AGY G S GGR AGR G R TGG TAG/TGA W * potential (resistance-associated) amino acid substitutions WT AA MZ AA NRT NNRTI PI INI AI EI Tropism G (Gly) S (Ser) G190S G73S G140S, G163S G357S G36S G11S G (Gly) R (Arg) G163R, G193R G11R, G25R G (Gly) E (Glu) G190E G16E G163E, G193E D (Asp) N (Asn) D67N D30N E (Glu) K (Lys) E138K E138K E25K R (Arg) Q (Gln) R (Arg) K (Lys) M (met) I (Ile) M184I M184I, M230I M36I, M46I M154I attention: differences in codon usage between subtypes

10 1.The political solution: sit it out just use the data as it is problem: M184I and M230I

11 2.The non-believer solution: ignore it remove all mutations that could occur from Apobec problem: M184I and M230I sometimes occur in the viral population really! M184I usually emerges before M184V which then outcompetes the M184I within several weeks of viral replication

12 2.The non-believer solution: ignore it

13 3.The linkage solution: link & delete idea: if several mutations possibly induced by Apobec have similar frequencies, then delete them otherwise stay with them

14 3.The linkage solution: link & delete idea: if several mutation possibly induced by Apobec have similar frequencies, then delete them otherwise stay with it mutation frequency M184I 12.4% M230I 14.6% W24* 15.7% W88* 13.3% W153* 13.3% G51R 16.4%......

15 3.The linkage solution: link & delete idea: if several mutations possibly induced by Apobec have similar frequencies, then delete them otherwise stay with them often works very well, but...

16 3.The linkage solution: link & delete

17 3.The linkage solution: link & delete idea: if several mutations possibly induced by Apobec have similar frequencies, then delete them otherwise stay with them often works very well, but... unfortunately not always

18 3.The linkage solution: link & delete idea: if several mutation possibly induced by Apobec have similar frequencies, then delete them otherwise stay with it often works very well, but... mutation frequency M184I 15.8% V82I 20.0% V108I 12.3% G190R 14.3% G84R (PR) 19.9% W153* 19.1% W71* 14.8% W88* 14.3%

19 3.The linkage solution: link & delete idea: if several mutation possibly induced by Apobec have similar frequencies, then delete them otherwise stay with it often works very well, but... how is the K103N affected? will it go below 10% do we remove them, too? mutation frequency M184I 15.8% V82I 20.0% V108I 12.3% G190R 14.3% G84R (PR) 19.9% W153* 19.1% W71* 14.8% W88* 14.3% L90M 21.1% L210W 14.3% T215Y 12.4% M230L 14.8%......

20 3.The linkage solution: link & delete idea: if several mutations possibly induced by Apobec have similar frequencies, then delete them otherwise stay with them often works very well, but... unfortunately not always we do not know how other mutations are affected how do the frequencies change?

21 4.The lazy solution: filter it automatically create a filtering method work on the reads themselves, not on the final result approach: naïve Bayes classifiers (related to Reuman et al., 2010)

22

23 4.The lazy solution: filter it automatically stops: the number of stop codons atypical aa: the number of atypical amino acid substitutions burden: #G-to-A / #G preference: #G-to-A / #substitutions

24 4.The lazy solution: filter it automatically trained on >100mio reads tested on 523 samples (111 DNA, 412 RNA) hypermutated reads 5% 10% 15% 20% 30% problems: DNA 19.82% 12.61% 11.71% 9.01% 4.50% RNA 15.05% 5.58% 1.46% 0.73% 0.00% too much weight on stop-codons less power on PR and IN

25 4.The lazy solution: filter it automatically

26 Acknowledgments Kirsten Becker Elisa Danner Nina Engel Anja Förster Anna Memmer Bettina Welter Martin Däumer Bernhard Thiele

Alexander Thielen 16th European Meeting on HIV & Hepatitis

Alexander Thielen 16th European Meeting on HIV & Hepatitis Dynamics of therapy options for HIV-1 infected patients with historical multi-drug resistance (MDR), based on deep-sequencing of proviral DNA First Results from the LOWER Study Alexander Thielen, Martin

More information

Deep-Sequencing of HIV-1

Deep-Sequencing of HIV-1 Deep-Sequencing of HIV-1 The quest for true variants Alexander Thielen, Martin Däumer 09.05.2015 Limitations of drug resistance testing by standard-sequencing Blood plasma RNA extraction RNA Reverse Transcription/

More information

New technologies reaching the clinic

New technologies reaching the clinic New technologies reaching the clinic Martin Däumer May 31, 2018 Deep-sequencing Standard Sanger-sequencing...PQIYMDDHTRE... Ultra-deep-sequencing...PQIYMDDHTRE......PQIYMDDHTRE......PQIYVDDHTRE......PQIYMDDHTRE......PQIYMDDHTRE......PQIYMDDHTRE...

More information

Resistance Workshop. 3rd European HIV Drug

Resistance Workshop. 3rd European HIV Drug 3rd European HIV Drug Resistance Workshop March 30-April 1 st, 2005 Christine Hughes, PharmD Clinical Associate Professor Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Tenofovir resistance

More information

RESEARCH B/F/TAF in Treatment-Naïve HIV-1 and HIV-1 RNA Suppressed Switch Patients

RESEARCH B/F/TAF in Treatment-Naïve HIV-1 and HIV-1 RNA Suppressed Switch Patients RESEARCH B/F/TAF in Treatment-Naïve HIV-1 and HIV-1 RNA Suppressed Switch Patients Kirsten White Gilead Sciences, Inc., Foster City, CA Background Bictegravir (BIC; B) is a novel, unboosted integrase strand

More information

Improving PI drug resistance scores. Jens Verheyen, MD Institute of Virology University Duisburg-Essen

Improving PI drug resistance scores. Jens Verheyen, MD Institute of Virology University Duisburg-Essen Improving PI drug resistance scores Jens Verheyen, MD Institute of Virology University Duisburg-Essen Overview Why can all PI drug resistance scores be improved? Do we still need to improve PI drug resistance

More information

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA HIV Genotypischer Resistenzalgorithmus Deutschland Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA Financial disclosure Study was financially supported by ViiV

More information

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European

More information

Chapter 12-4 DNA Mutations Notes

Chapter 12-4 DNA Mutations Notes Chapter 12-4 DNA Mutations Notes I. Mutations Introduction A. Definition: Changes in the DNA sequence that affect genetic information B. Mutagen= physical or chemical agent that interacts with DNA to cause

More information

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop 12/9/16. Introduction. ARS Question

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop 12/9/16. Introduction. ARS Question Disclosures Introduction to ARV Drug Resistance New Clinicians Workshop I have no disclosures Susa Coffey, MD Division of HIV, ID and Global Medicine ARS Question Which resistance test do you order for

More information

Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays

Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays Christian Pou 1, Rocío Bellido 1, Francisco M. Codoñer 1, Alexander Thielen 3, Cecilia Cabrera 1, Judith Dalmau

More information

geno2pheno[ngs-freq]: a novel tool for drug resistance testing in the era of nextgeneration

geno2pheno[ngs-freq]: a novel tool for drug resistance testing in the era of nextgeneration geno2pheno[ngs-freq]: a novel tool for drug resistance testing in the era of nextgeneration sequencing Matthias Döring Max Planck Institute for Informatics AREVIR Meeting 2018 - New Strategies - May 9,

More information

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop. Introduction. ARS Question 12/6/2017

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop. Introduction. ARS Question 12/6/2017 Disclosures Introduction to ARV Drug Resistance New Clinicians Workshop I have no disclosures Susa Coffey, MD Division of HIV, ID and Global Medicine ARS Question Which resistance test do you order for

More information

History (August 2010) Therapy for Experienced Patients. History (September 2010) History (November 2010) 12/2/11

History (August 2010) Therapy for Experienced Patients. History (September 2010) History (November 2010) 12/2/11 (August 2010) Therapy for Experienced Patients Hiroyu Hatano, MD, MHS Assistant Professor of Medicine University of California San Francisco Medical Management of AIDS December 2011 42M HIV (CD4=450, VL=6250,

More information

DNA Genotyping in HIV Infection

DNA Genotyping in HIV Infection Frontier AIDS Education and Training Center DNA Genotyping in HIV Infection Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS Clinical Program; Professor of Medicine, Division of Infectious

More information

Finding protein sites where resistance has evolved

Finding protein sites where resistance has evolved Finding protein sites where resistance has evolved The amino acid (Ka) and synonymous (Ks) substitution rates Please sit in row K or forward The Berlin patient: first person cured of HIV Contracted HIV

More information

Rajesh Kannangai Phone: ; Fax: ; *Corresponding author

Rajesh Kannangai   Phone: ; Fax: ; *Corresponding author Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal

More information

Somnuek Sungkanuparph, M.D.

Somnuek Sungkanuparph, M.D. HIV Drug Resistance Somnuek Sungkanuparph, M.D. Associate Professor Division of Infectious Diseases Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University Adjunct Professor

More information

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop. Introduction. ARS Question

Disclosures. Introduction to ARV Drug Resistance New Clinicians Workshop. Introduction. ARS Question Disclosures Introduction to ARV Drug Resistance New Clinicians Workshop I have no disclosures Susa Coffey, MD Division of HIV, ID and Global Medicine ARS Question Which resistance test do you order for

More information

2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012

2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012 2 nd Line Treatment and Resistance Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012 Overview Basics of Resistance Treatment failure Strategies to manage treatment failure Mutation Definition: A change

More information

BIOCHEMISTRY REVIEW. Overview of Biomolecules. Chapter 4 Protein Sequence

BIOCHEMISTRY REVIEW. Overview of Biomolecules. Chapter 4 Protein Sequence BIOCHEMISTRY REVIEW Overview of Biomolecules Chapter 4 Protein Sequence 2 3 4 Are You Getting It?? A molecule of hemoglobin is compared with a molecule of lysozyme. Which characteristics do they share?

More information

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Homework Watch the Bozeman video called, Biological Molecules Objective:

More information

APACC 2016 HIV drug resistance. Shinichi Oka, MD, PhD. AIDS Clinical Center (ACC) National Center for Global Health and Medicine (NCGM)

APACC 2016 HIV drug resistance. Shinichi Oka, MD, PhD. AIDS Clinical Center (ACC) National Center for Global Health and Medicine (NCGM) APACC 2016 HIV drug resistance Shinichi Oka, MD, PhD. AIDS Clinical Center (ACC) National Center for Global Health and Medicine (NCGM) HIV drug resistance 1. Current situation of ART and TDR in Japan 2.

More information

Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence

Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence D. Borley, S. Upadhyaya, D. Paton, R. Reeve and Mana Mahapatra Pirbright Laboratory United Kingdom

More information

Management of NRTI Resistance

Management of NRTI Resistance NORTHWEST AIDS EDUCATION AND TRAINING CENTER Management of NRTI Resistance David Spach, MD Principal Investigator, NW AETC Professor of Medicine, Division of Infectious Diseases University of Washington

More information

Amino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3

Amino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3 Fundamentals While their name implies that amino acids are compounds that contain an 2 group and a 2 group, these groups are actually present as 3 and 2 respectively. They are classified as α, β, γ, etc..

More information

Transmission of integrase resistance HIV

Transmission of integrase resistance HIV Transmission of integrase resistance HIV Charles Boucher, MD, PhD Clinical Virology, Dept. Viroscience, Erasmus Medical Center, Erasmus Universiy, The Netherlands Major resistance mutations (Stanford)

More information

Objective: You will be able to explain how the subcomponents of

Objective: You will be able to explain how the subcomponents of Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:

More information

NNRTI Resistance NORTHWEST AIDS EDUCATION AND TRAINING CENTER

NNRTI Resistance NORTHWEST AIDS EDUCATION AND TRAINING CENTER NORTHWEST AIDS EDUCATION AND TRAINING CENTER NNRTI Resistance David H. Spach, MD Principal Investigator, NW AETC Professor of Medicine, Division of Infectious Diseases University of Washington Last Updated:

More information

Supplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular

Supplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular Supplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular weight markers (M). Supplementary Figure-2. Overlay of

More information

HIV, HBV, HCV Virology. Anna Maria Geretti Institute of Infection & Global Health University of Liverpool

HIV, HBV, HCV Virology. Anna Maria Geretti Institute of Infection & Global Health University of Liverpool HIV, HBV, HCV Virology Anna Maria Geretti Institute of Infection & Global Health University of Liverpool HIV HBV HCV Many similarities Several fundamental differences High-level replication: HIV 10 10,

More information

1. Describe the relationship of dietary protein and the health of major body systems.

1. Describe the relationship of dietary protein and the health of major body systems. Food Explorations Lab I: The Building Blocks STUDENT LAB INVESTIGATIONS Name: Lab Overview In this investigation, you will be constructing animal and plant proteins using beads to represent the amino acids.

More information

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan JOURNAL OF VIROLOGY, May 2000, p. 4335 4350 Vol. 74, No. 9 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Reevaluation of Amino Acid Variability of the Human

More information

Second-Line Therapy NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Second-Line Therapy NORTHWEST AIDS EDUCATION AND TRAINING CENTER NORTHWEST AIDS EDUCATION AND TRAINING CENTER Second-Line Therapy David Spach, MD Clinical Director, Northwest AETC Professor of Medicine, Division of Infectious Diseases University of Washington Presentation

More information

The Basics: A general review of molecular biology:

The Basics: A general review of molecular biology: The Basics: A general review of molecular biology: DNA Transcription RNA Translation Proteins DNA (deoxy-ribonucleic acid) is the genetic material It is an informational super polymer -think of it as the

More information

Evaluation and Management of Virologic Failure

Evaluation and Management of Virologic Failure National HIV Curriculum PDF created November 3, 2018, 12:26 am Evaluation and Management of Virologic Failure This is a PDF version of the following document: Section 1: Antiretroviral Therapy Topic 5:

More information

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action

More information

Antiretroviral Prophylaxis and HIV Drug Resistance. John Mellors University of Pittsburgh

Antiretroviral Prophylaxis and HIV Drug Resistance. John Mellors University of Pittsburgh Antiretroviral Prophylaxis and HIV Drug Resistance John Mellors University of Pittsburgh MTN Annual 2008 Outline Two minutes on terminology Origins of HIV drug resistance Lessons learned from ART Do these

More information

Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V

Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V Christian Callebaut, PhD Gilead Sciences, Foster City, CA, USA HIV DART AND EMERGING VIRUSES 12/08/2016

More information

Resistance to Integrase Strand Transfer Inhibitors

Resistance to Integrase Strand Transfer Inhibitors NORTHWEST AIDS EDUCATION AND TRAINING CENTER Resistance to Integrase Strand Transfer Inhibitors David Spach, MD Clinical Director, Northwest AETC Professor of Medicine, Division of Infectious Diseases

More information

Disclosure. Relations that could be relevant for the meeting

Disclosure. Relations that could be relevant for the meeting HIV drug resistance A.M.J. Wensing, MD, PhD Senior Consultant Virology, University Medical Center, Utrecht Honorary Professor, University of Witwatersrand, Johannesburg Disclosure Relations that could

More information

Genotyping and Drug Resistance in Clinical Practice. Case Studies

Genotyping and Drug Resistance in Clinical Practice. Case Studies Genotyping and Drug Resistance in Clinical Practice Case Studies 12/02 40 year old Hispanic male Dx with HIV 1995 + Hx of PCP > 1x, HepC Medication history: AZT, Crixivan, Videx EC, Sustiva, Zerit, Ziagen,

More information

Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naïve Subjects with Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762)

Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naïve Subjects with Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762) Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naïve Subjects with Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762) MR Underwood 1, F DeAnda 1, D Dorey 2, K Hightower 1,

More information

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Joel O. Wertheim 1,2, Alexandra M. Oster 3, Jeffrey A. Johnson 3, William M. Switzer 3, Neeraja Saduvala

More information

Prevalence of Transmitted Drug Resistance Mutations among Naive HIV-infected patients ( ) in Northwest Spain

Prevalence of Transmitted Drug Resistance Mutations among Naive HIV-infected patients ( ) in Northwest Spain Prevalence of Transmitted Drug Resistance Mutations among Naive HIV-infected patients (2014-2016) in Northwest Spain Berta Pernas 1, Andrés Tabernilla 1, Marta Grandal 1, Angelina Cañizares 2, Sofía Ortún

More information

The E138A substitution in HIV-1 reverse transcriptase decreases in vitro. susceptibility to emtricitabine as indicated by competitive fitness assays

The E138A substitution in HIV-1 reverse transcriptase decreases in vitro. susceptibility to emtricitabine as indicated by competitive fitness assays AAC Accepts, published online ahead of print on 13 January 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.02114-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 The E138A

More information

CHAPTER 21: Amino Acids, Proteins, & Enzymes. General, Organic, & Biological Chemistry Janice Gorzynski Smith

CHAPTER 21: Amino Acids, Proteins, & Enzymes. General, Organic, & Biological Chemistry Janice Gorzynski Smith CHAPTER 21: Amino Acids, Proteins, & Enzymes General, Organic, & Biological Chemistry Janice Gorzynski Smith CHAPTER 21: Amino Acids, Proteins, Enzymes Learning Objectives: q The 20 common, naturally occurring

More information

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule.

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule. This exam is worth 90 points. Pages 2- have questions. Page 1 is for your reference only. Honor Code Agreement - Signature: Date: (You agree to not accept or provide assistance to anyone else during this

More information

Properties of amino acids in proteins

Properties of amino acids in proteins Properties of amino acids in proteins one of the primary roles of DNA (but far from the only one!!!) is to code for proteins A typical bacterium builds thousands types of proteins, all from ~20 amino acids

More information

Protein Synthesis and Mutation Review

Protein Synthesis and Mutation Review Protein Synthesis and Mutation Review 1. Using the diagram of RNA below, identify at least three things different from a DNA molecule. Additionally, circle a nucleotide. 1) RNA is single stranded; DNA

More information

Charges on amino acids and proteins. ph 1. ph 7. Acidic side chains: glutamate and aspartate

Charges on amino acids and proteins. ph 1. ph 7. Acidic side chains: glutamate and aspartate harges on amino acids and proteins Acidic side chains: glutamate and aspartate A A- + + + - + Basic side chains: arginine, lysine & histidine Glycine @ p 1 B+ B + + + The amino group, pka 9.6 3 N+ The

More information

TRANSLATION: 3 Stages to translation, can you guess what they are?

TRANSLATION: 3 Stages to translation, can you guess what they are? TRANSLATION: Translation: is the process by which a ribosome interprets a genetic message on mrna to place amino acids in a specific sequence in order to synthesize polypeptide. 3 Stages to translation,

More information

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite) Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes

More information

Switching strategies and ARV treatment costs

Switching strategies and ARV treatment costs February 2014 Switching strategies and ARV treatment costs Josep M Llibre/Bonaventura Clotet Fundació Lluita contra la SIDA Hosp Univ Germans Trias i Pujol Badalona Rationale. Spain is under a huge economic

More information

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review pissn 2349-2910 eissn 2395-0684 REVIEW Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review Dinesh Bure, Department

More information

HIV Drug Resistance among Adolescents and Young Adults Failing HIV Therapy in Zimbabwe

HIV Drug Resistance among Adolescents and Young Adults Failing HIV Therapy in Zimbabwe HIV Drug Resistance among Adolescents and Young Adults Failing HIV Therapy in Zimbabwe V Kouamou 1, J Manasa 1, D Katzenstein 1, A McGregor 1, CE Ndhlovu 1 & AT Makadzange 1. 1 University of Zimbabwe Introduction

More information

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with

More information

Management of patients with antiretroviral treatment failure: guidelines comparison

Management of patients with antiretroviral treatment failure: guidelines comparison The editorial staff Management of patients with antiretroviral treatment failure: guidelines comparison A change of therapy should be considered for patients if they experience sustained rebound in viral

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Determination of Unbound Urinary Amino Acids Incorporated with Creatinine Normalization by LC-MS/MS Method with CLAM-2000 Online Sample Pre-treatment

Determination of Unbound Urinary Amino Acids Incorporated with Creatinine Normalization by LC-MS/MS Method with CLAM-2000 Online Sample Pre-treatment PO-CON133E Determination of Unbound Urinary Amino Acids Incorporated with Creatinine Normalization by LC-MS/MS Method with CLAM-2000 Online Sample Pre-treatment ASMS 201 WP 34 Zhe Sun 1, Jie Xing 1, Ei

More information

Genetic information flows from mrna to protein through the process of translation

Genetic information flows from mrna to protein through the process of translation Genetic information flows from mrn to protein through the process of translation TYPES OF RN (RIBONUCLEIC CID) RN s job - protein synthesis (assembly of amino acids into proteins) Three main types: 1.

More information

PRINCIPLES and TRENDS in MANAGEMENT of HIV DISEASE: PROBLEMS OF DRUG RESISTANCE in VIRUSES of DIFFERENT SUBTYPES

PRINCIPLES and TRENDS in MANAGEMENT of HIV DISEASE: PROBLEMS OF DRUG RESISTANCE in VIRUSES of DIFFERENT SUBTYPES PRINCIPLES and TRENDS in MANAGEMENT of HIV DISEASE: PROBLEMS OF DRUG RESISTANCE in VIRUSES of DIFFERENT SUBTYPES Mark A. Wainberg McGill University AIDS Centre Jewish General Hospital Montreal, Quebec,

More information

The composition of macromolecular cellular composition of mouse cell lines can be found

The composition of macromolecular cellular composition of mouse cell lines can be found Supplementary 2: Cell biomass composition The composition of macromolecular cellular composition of mouse cell lines can be found elsewhere. 1-5 Following table shows the percentage composition of important

More information

The Journal of Infectious Diseases BRIEF REPORT

The Journal of Infectious Diseases BRIEF REPORT The Journal of Infectious Diseases BRIEF REPORT Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1 Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger

More information

Towards a New Paradigm in Scientific Notation Patterns of Periodicity among Proteinogenic Amino Acids [Abridged Version]

Towards a New Paradigm in Scientific Notation Patterns of Periodicity among Proteinogenic Amino Acids [Abridged Version] Earth/matriX: SCIENCE TODAY Towards a New Paradigm in Scientific Notation Patterns of Periodicity among Proteinogenic Amino Acids [Abridged Version] By Charles William Johnson Earth/matriX Editions P.O.

More information

Update on HIV Drug Resistance. Daniel R. Kuritzkes, MD Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School

Update on HIV Drug Resistance. Daniel R. Kuritzkes, MD Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School Update on HIV Drug Resistance Daniel R. Kuritzkes, MD Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School Learning Objectives Upon completion of this presentation, learners

More information

I m B m. 1 f ub I B. D m B. f u. 1 f ua 1 D I A. I A m. D m A. f a. 1 f u. D m B ) D m A )(I m B. 1 f ua. 1 (I m A. log (I A. log f.

I m B m. 1 f ub I B. D m B. f u. 1 f ua 1 D I A. I A m. D m A. f a. 1 f u. D m B ) D m A )(I m B. 1 f ua. 1 (I m A. log (I A. log f. Supplementary Material Appendix 1 Here we show that independent inhibition by a single drug of two distinct steps (A and ) in the viral life cycle results in a non-linear median effect dose-response curve

More information

ELECTRONIC SUPPLEMENTARY MATERIAL - Cellular and Molecular Life Sciences -

ELECTRONIC SUPPLEMENTARY MATERIAL - Cellular and Molecular Life Sciences - ELECTRONIC SUPPLEMENTARY MATERIAL - Cellular and Molecular Life Sciences - Single nucleotide evolution quantifies the importance of each site along the structure of mitochondrial carriers Ciro Leonardo

More information

Cahn - Ingold - Prelog system. Proteins: Evolution, and Analysis Lecture 7 9/15/2009. The Fischer Convention (1) G (2) (3)

Cahn - Ingold - Prelog system. Proteins: Evolution, and Analysis Lecture 7 9/15/2009. The Fischer Convention (1) G (2) (3) Chapter 4 (1) G Proteins: Evolution, and Analysis Lecture 7 9/15/2009 A V L I M P F W Chapter 4 (2) S (3) T N Q Y C K R H D E The Fischer Convention Absolute configuration about an asymmetric carbon related

More information

14 TH EUROPEAN HIV & HEPATITIS MEETING Abst#_O_06

14 TH EUROPEAN HIV & HEPATITIS MEETING Abst#_O_06 14 TH EUROPEAN HIV & HEPATITIS MEETING 2016 Abst#_O_06 Patients with pre-existent NRTI- and NNRTI-resistance have a higher risk to lose virological suppression under tenofovir/emtricitabine/rilpivirine

More information

LAB#23: Biochemical Evidence of Evolution Name: Period Date :

LAB#23: Biochemical Evidence of Evolution Name: Period Date : LAB#23: Biochemical Evidence of Name: Period Date : Laboratory Experience #23 Bridge Worth 80 Lab Minutes If two organisms have similar portions of DNA (genes), these organisms will probably make similar

More information

Introduction to HIV Drug Resistance. Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School

Introduction to HIV Drug Resistance. Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School Introduction to HIV Drug Resistance Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School Objectives 1. Describe the epidemiology of HIV drug resistance in sub-saharan Africa. 2.

More information

Resistance Characteristics of Integrase Inhibitors

Resistance Characteristics of Integrase Inhibitors Resistance Characteristics of Integrase Inhibitors Madrid, November 2016 Jonathan M Schapiro, MD National Hemophilia Center, Israel Stanford University School of Medicine, USA Disclaimer Presentation includes

More information

Mapping evolutionary pathways of HIV-1 drug resistance using conditional selection pressure. Christopher Lee, UCLA

Mapping evolutionary pathways of HIV-1 drug resistance using conditional selection pressure. Christopher Lee, UCLA Mapping evolutionary pathways of HIV-1 drug resistance using conditional selection pressure Christopher Lee, UCLA HIV-1 Protease and RT: anti-retroviral drug targets protease RT Protease: responsible for

More information

Reading from the NCBI

Reading from the NCBI Reading from the NCBI http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=thermodyn amics&rid=stryer.section.156#167 http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=stability,pr otein&rid=stryer.section.365#371

More information

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC

More information

Mutations to Integrase Inhibitors in real life

Mutations to Integrase Inhibitors in real life Mutations to Integrase Inhibitors in real life González-Domenech CM, Viciana I, Sena Corrales G, Delgado M, De la Torre J, Torres Tortosa M, Téllez F, Jarilla F, Clavijo E, Santos J BACKGROUND INSTI Block

More information

AA s are the building blocks of proteins

AA s are the building blocks of proteins Chamras Chemistry 106 Lecture otes Chapter 24: Amino Acids, Peptides, and Proteins General Formula: () n (') α-amino Acids: (n = 1) Example: Amino Acids and Proteins: Glycine Alanine Valine AA s are the

More information

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

HIV and drug resistance Simon Collins UK-CAB 1 May 2009 HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk Tip of the iceberg = HIV result, CD4, VL Introduction: resistance

More information

HIV Drug Resistance: An Overview

HIV Drug Resistance: An Overview Human Journals Review Article October 2015 Vol.:1, Issue:1 All rights are reserved by Suraj Narayan Mali et al. HIV Drug Resistance: An Overview Keywords: HIV drug resistance mechanism, Antiretroviral

More information

Protein Synthesis. What are proteins and what are they composed of? What are some of their functions? What determines the final function of a protein?

Protein Synthesis. What are proteins and what are they composed of? What are some of their functions? What determines the final function of a protein? Protein Synthesis What are proteins and what are they composed of? What are some of their functions? What determines the final function of a protein? What is needed to make specific proteins and what is

More information

Hepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization. Arevir Meeting, 08./09.05.

Hepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization. Arevir Meeting, 08./09.05. Hepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization Arevir Meeting, 08./09.05.2014 Daniel Rupp HCV prevalence 130-170 million patients world wide Ca. 75% of infections

More information

Molecular Surveillance of Recent HIV-Infections in Germany. Priv.-Doz. Dr. Norbert Bannert "HIV und Other Retroviruses" Robert Koch-Institut, Berlin

Molecular Surveillance of Recent HIV-Infections in Germany. Priv.-Doz. Dr. Norbert Bannert HIV und Other Retroviruses Robert Koch-Institut, Berlin Molecular Surveillance of Recent HIV-Infections in Germany Priv.-Doz. Dr. Norbert Bannert "HIV und Other Retroviruses" Robert Koch-Institut, Berlin AREVIR-Meeting, May 9th 2015 Sampling of New HIV Diagnoses

More information

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry Dr. Sanjeeva Srivastava 1. Fundamental of Mass Spectrometry Role of MS and basic concepts 2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry 2 1 MS basic concepts Mass spectrometry - technique

More information

Update on HIV-1 Drug Resistance and Tropism Testing

Update on HIV-1 Drug Resistance and Tropism Testing Update on HIV-1 Drug Resistance and Tropism Testing Daniel R. Kuritzkes, MD Section of Retroviral Therapeutics Brigham and Women s Hospital Harvard Medical School ACTHIV 2011: A State-of-the-Science Conference

More information

172R 172K TAM-2/172R TAM-2/172K. AZT concentration [nm] AZT concentration [nm] MgCl 2 2.5K 2.5K 5K 2.5K 5K 2.5K K 5K 2.5K 5K 2.5K 50 2.

172R 172K TAM-2/172R TAM-2/172K. AZT concentration [nm] AZT concentration [nm] MgCl 2 2.5K 2.5K 5K 2.5K 5K 2.5K K 5K 2.5K 5K 2.5K 50 2. 5 5 5 5 A MgCl 2 172R 172K TAM-2/172R TAM-2/172K AZT concentration [nm] B 172R 172K TAM-2/172R TAM-2/172K AZT concentration [nm] ATP + ATP - Supplemental Figure 1. Primer extension of HIV-1 RT polymorphisms

More information

Methionine (Met or M)

Methionine (Met or M) Fig. 5-17 Nonpolar Fig. 5-17a Nonpolar Glycine (Gly or G) Alanine (Ala or A) Valine (Val or V) Leucine (Leu or L) Isoleucine (Ile or I) Methionine (Met or M) Phenylalanine (Phe or F) Polar Trypotphan (Trp

More information

Microbiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2

Microbiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2 The Incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory,

More information

Chapter 4: Information and Knowledge in the Protein Insulin

Chapter 4: Information and Knowledge in the Protein Insulin Chapter 4: Information and Knowledge in the Protein Insulin This chapter will calculate the information and molecular knowledge in a real protein. The techniques discussed in this chapter to calculate

More information

Can we learn something new about peptide separations after 40 years of RP and HILIC chromatography? Martin Gilar April 12, MASSEP 2016

Can we learn something new about peptide separations after 40 years of RP and HILIC chromatography? Martin Gilar April 12, MASSEP 2016 Can we learn something new about peptide separations after 40 years of RP and HILIC chromatography? Martin Gilar April 12, MASSEP 2016 2015 Waters Corporation 1 Overview 1. 2D RP RP LC of peptides 2. RP-LC

More information

Integration Solutions

Integration Solutions Integration Solutions (1) a) With no active glycosyltransferase of either type, an ii individual would not be able to add any sugars to the O form of the lipopolysaccharide. Thus, the only lipopolysaccharide

More information

Identification of a Single Amino Acid Required for APOBEC3 Antiretroviral Cytidine Deaminase Activity

Identification of a Single Amino Acid Required for APOBEC3 Antiretroviral Cytidine Deaminase Activity JOURNAL OF VIROLOGY, June 2011, p. 5691 5695 Vol. 85, No. 11 0022-538X/11/$12.00 doi:10.1128/jvi.00243-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Identification of a Single

More information

Copyright 2008 Pearson Education, Inc., publishing as Pearson Benjamin Cummings

Copyright 2008 Pearson Education, Inc., publishing as Pearson Benjamin Cummings Concept 5.4: Proteins have many structures, resulting in a wide range of functions Proteins account for more than 50% of the dry mass of most cells Protein functions include structural support, storage,

More information

Amino acids-incorporated nanoflowers with an

Amino acids-incorporated nanoflowers with an Amino acids-incorporated nanoflowers with an intrinsic peroxidase-like activity Zhuo-Fu Wu 1,2,+, Zhi Wang 1,+, Ye Zhang 3, Ya-Li Ma 3, Cheng-Yan He 4, Heng Li 1, Lei Chen 1, Qi-Sheng Huo 3, Lei Wang 1,*

More information

Molecular Biology. general transfer: occurs normally in cells. special transfer: occurs only in the laboratory in specific conditions.

Molecular Biology. general transfer: occurs normally in cells. special transfer: occurs only in the laboratory in specific conditions. Chapter 9: Proteins Molecular Biology replication general transfer: occurs normally in cells transcription special transfer: occurs only in the laboratory in specific conditions translation unknown transfer:

More information

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length

More information

Innovative diagnostics for HIV, HBV and HCV

Innovative diagnostics for HIV, HBV and HCV Innovative diagnostics for HIV, HBV and HCV Dan Otelea National Institute for Infectious Diseases Bucharest, Romania Disclaimer No conflicts of interest Innovative diagnostics for HIV, HBV and HCV - is

More information

Introduction to Peptide Sequencing

Introduction to Peptide Sequencing Introduction to Peptide equencing Quadrupole Ion Traps tructural Biophysics Course December 3, 2014 12/8/14 Introduction to Peptide equencing - athan Yates 1 Why are ion traps used to sequence peptides?

More information

Review Article HIV-1 Genetic Variability and Clinical Implications

Review Article HIV-1 Genetic Variability and Clinical Implications ISRN Microbiology Volume 2013, Article ID 481314, 20 pages http://dx.doi.org/10.1155/2013/481314 Review Article HIV-1 Genetic Variability and Clinical Implications Maria Mercedes Santoro 1 and Carlo Federico

More information

International Journal of Pharma and Bio Sciences V1(2)2010 IN SILICO PHARMACOGENOMIC ANALYSIS OF ALCOHOL DEHYDROGENASE INVOLVED IN ALCOHOLISM

International Journal of Pharma and Bio Sciences V1(2)2010 IN SILICO PHARMACOGENOMIC ANALYSIS OF ALCOHOL DEHYDROGENASE INVOLVED IN ALCOHOLISM SINGH SATENDRA, MECARTY S. D., JAIN P.A., GAUTAM B., FARMER R., YADAV P.K. AND RAM G.D. 1 Department of Computational Biology & Bioinformatics, JSBBE, SHIATS, Allahabad-211007,India 1 Department of Tissue

More information